Mesenteric (or intestinal) artery disease is a condition that develops when the arteries in the abdomen that supply the intestines become narrowed, or blocked, by an accumulation of a fatty substance ...
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
Evrysdi is the only non-invasive disease-modifying treatment for SMA. The 5 mg Evrysdi tablet can either be swallowed whole or dispersed in water. “Evrysdi has robust potential to modify the SMA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback